Skip to main content
Equibles

Woodline Partners LP

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1784547 San Francisco, CA
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,639,976
-$4,148,077 QoQ
Shares Held
2,500,532
-9.1% QoQ
Ownership
3.05%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#14
of 141 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. LXEO ranks #87 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in LXEO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,639,976 2,500,532
2026-03-31 $15,788,053 2,750,532
2025-12-31 $31,753,756 3,197,760
2025-09-30 $17,079,155 2,572,162
2025-06-30 $10,340,091 2,572,162
2025-03-31 $2,904,438 837,014
2024-12-31 $5,650,186 858,691
2024-09-30 $7,701,727 851,961
2024-06-30 $13,218,146 824,074
2024-03-31 $188,959 12,051